Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Article
  • Published:

Prospective study to analyze the yield and clinical impact of trio exome sequencing in 137 Indian children with autism spectrum disorder

Abstract

We aimed to study the diagnostic yield and clinical impact of trio exome sequencing (tES) in children with autism spectrum disorder (ASD). Participants (n = 137) between 2 and 18 years with syndromic and non-syndromic ASD underwent tES, after excluding karyotype-detectable cytogenetic abnormalities and fragile X syndrome. The diagnostic yield was 22/137 (16.1%) when considering only pathogenic (P) and likely-pathogenic (LP) variants in known disease-causing genes. We reported 23 significant (P, LP) variants in 22 individuals, with one participant (AGS041) harbouring a dual genetic diagnosis. Nearly half of these (12/23, 52.2%) were novel, while 21/23 (91.3%) occurred de novo. 20/23 (86.9%) of the variants were single nucleotide variants, while 3/23 (13.1%) were copy number variants. The diagnostic yield in syndromic ASD (14/40, 35%) was significantly higher than the non-syndromic group (8/97, 8.2%, p = 0.000258). Variants of uncertain significance in two participants were considered to be likely causative for the phenotype, given the strong clinical correlation (likely-causative variant of uncertain significance, LcVUS). On considering these two participants and an additional 28 participants with significant variants in autism candidate genes (vACG), the net diagnostic yield increased to 37.9%. The clinical benefits among those receiving a definite genetic diagnosis (P/LP variants only) included better prognostication (100%), availing reproductive counselling (100%), disease-specific surveillance (86.4%), and therapeutic implications (27.3%). Thus, in conclusion, in our cohort of 137 children with ASD, tES provided a definite genetic diagnosis in 16.1% of the participants, the yield being higher in syndromic ASD. A confirmed genetic diagnosis aided in holistic clinical care, extending beyond reproductive counselling.

This is a preview of subscription content, access via your institution

Access options

Buy this article

USD 39.95

Prices may be subject to local taxes which are calculated during checkout

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

Data availability

The data that support the findings of this study is available on request from the corresponding author. The data is not publicly available due to privacy or ethical restrictions.

References

  1. Lord C, Elsabbagh M, Baird G, Veenstra-Vanderweele J. Autism Spectrum Disorder. Nat Rev Dis Prim. 2020;6:5.

    Article  PubMed  Google Scholar 

  2. Lai MC, Lombardo MV, Baron-Cohen S. Autism. Lancet. 2014;383:896–910.

    Article  PubMed  Google Scholar 

  3. Gaugler T, Klei L, Sanders SJ, Bodea CA, Goldberg AP, Lee AB, et al. Most Genetic Risk For Autism Resides With Common Variation. Nat Genet. 2014;46:881–5.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Sandin S, Lichtenstein P, Kuja-Halkola R, Larsson H, Hultman CM, Reichenberg A. The Familial Risk Of Autism. JAMA. 2014;311:1770–7.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Sandin S, Lichtenstein P, Kuja-Halkola R, Hultman CM, Larsson H, Reichenberg A. The Heritability of Autism Spectrum Disorder. JAMA. 2017;318:1182–4.

    Article  PubMed  PubMed Central  Google Scholar 

  6. Chattopadhyay N. Autism Screening in India: Many a Chasm to Bridge. Indian Pediatr. 2024;61:321–2.

    Article  PubMed  Google Scholar 

  7. Nakatsuka N, Moorjani P, Rai N, Sarkar B, Tandon A, Patterson N, et al. The Promise of Discovering Population-Specific Disease-Associated Genes in South Asia. Nat Genet. 2017;49:1403–7.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Sheth F, Shah J, Jain D, Shah S, Patel H, Patel K, et al. Comparative Yield of Molecular Diagnostic Algorithms For Autism Spectrum Disorder Diagnosis in India: Evidence Supporting Whole Exome Sequencing As First-Tier Test. BMC Neurol. 2023;23:292.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Arora K, Balwani M, Wakchaure A, Passi GR. Yield of Genetic Testing in Children With Autism Spectrum Disorder: A Single-Center Experience. Ann Indian Acad Neurol. 2025;28:253–6.

  10. Manickam K, McClain MR, Demmer LA, Biswas S, Kearney HM, Malinowski J, et al. ACMG Board of Directors. Exome and genome sequencing for pediatric patients with congenital anomalies or intellectual disability: An evidence-based clinical guideline of the American College of Medical Genetics and Genomics (ACMG). Genet Med. 2021;23:2029–37.

    Article  PubMed  Google Scholar 

  11. Arteche-López A, Gómez Rodríguez MJ, Sánchez Calvin MT, Quesada-Espinosa JF, Lezana Rosales JM, Palma Milla C, et al. Towards a Change In The Diagnostic Algorithm Of Autism Spectrum Disorders: Evidence Supporting Whole Exome Sequencing as a First-Tier Test. Genes (Basel). 2021;12:560.

    Article  PubMed  Google Scholar 

  12. Schaefer GB, Mendelsohn NJ, Professional P, Guidelines C. Clinical Genetics Evaluation In Identifying The Etiology Of Autism Spectrum Disorders: 2013 Guideline Revisions. Genet Med. 2013;15:399–407.

    Article  CAS  PubMed  Google Scholar 

  13. Hellquist A, Tammimies K. Access, Utilization, And Awareness For Clinical Genetic Testing In Autism Spectrum Disorder in Sweden: A survey study. Autism. 2022;26:1795–804.

    Article  PubMed  Google Scholar 

  14. Smith HS, Franciskovich R, Lewis AM, Gerard A, Littlejohn RO, Nugent K, et al. Outcomes Of Prior Authorization Requests For Genetic Testing In Outpatient Pediatric Genetics Clinics. Genet Med. 2021;23:950–5.

    Article  PubMed  Google Scholar 

  15. Stafford CF, Sanchez-Lara PA. Impact Of Genetic And Genomic Testing On The Clinical Management Of Patients With Autism Spectrum Disorder. Genes (Basel). 2022;13:585.

    Article  CAS  PubMed  Google Scholar 

  16. Chen J, Bardes EE, Aronow BJ, Jegga AG. ToppGene Suite for Gene List Enrichment Analysis And Candidate Gene Prioritization. Nucleic Acids Res. 2009;ume 37:W305–W311.

    Article  Google Scholar 

  17. Online Mendelian Inheritance in Man, OMIM®. McKusick-Nathans Institute of Genetic Medicine, Johns Hopkins University (Baltimore, MD) [Internet]. [cited 2024 Dec 20]. Available from: https://omim.org/.

  18. Singh A, Balasundaram MK, Gupta D. Trofinetide in Rett Syndrome: A Brief Review of Safety And Efficacy. Intractable Rare Dis Res. 2023;12:262–6. https://doi.org/10.5582/irdr.2023.01060.

    Article  PubMed  PubMed Central  Google Scholar 

  19. Tedesco Silva LM, Sharma S, Schrauwen I, Margolesky J, Detyniecki K. A de novo HECW2 Variant In A Patient With Acetazolamide-Responsive Episodic Ataxia. Cerebellum. 2023;22:1029–33.

    Article  PubMed  Google Scholar 

  20. Mercimek-Andrews S. STXBP1 encephalopathy with epilepsy. 2016 Dec 1 [updated 2023 Sep 28]. In: Adam MP, Feldman J, Mirzaa GM, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993–2024. Available from: https://www.ncbi.nlm.nih.gov/books/NBK396561/

  21. Freibauer A, Wohlleben M, Boelman C. STXBP1-Related Disorders: Clinical Presentation, Molecular Function, Treatment, And Future Directions. Genes (Basel). 2023;14:2179.

    Article  CAS  PubMed  Google Scholar 

  22. Feliciano P, Zhou X, Astrovskaya I, Turner TN, Wang T, Brueggeman L, et al. Exome Sequencing of 457 Autism Families Recruited Online Provides Evidence For Autism Risk Genes. NPJ Genom Med. 2019;4:19–22.

    Article  PubMed  PubMed Central  Google Scholar 

  23. Martinez-Granero F, Blanco-Kelly F, Sanchez-Jimeno C, Avila-Fernandez A, Arteche A, Bustamante-Aragones A, et al. Comparison of The Diagnostic Yield Of Acgh And Genome-Wide Sequencing Across Different Neurodevelopmental Disorders. NPJ Genom Med. 2021;6:25.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  24. Shen Y, Dies KA, Holm IA, Bridgemohan C, Sobeih MM, Caronna EB, et al. Clinical Genetic Testing For Patients With Autism Spectrum Disorders. Pediatrics. 2010;125:e727–35.

    Article  PubMed  Google Scholar 

  25. Tammimies K, Marshall CR, Walker S, Kaur G, Thiruvahindrapuram B, Lionel AC, et al. Molecular Diagnostic Yield Of Chromosomal Microarray Analysis And Whole-Exome Sequencing In Children With Autism Spectrum Disorder. JAMA. 2015;314:895–903.

    Article  CAS  PubMed  Google Scholar 

  26. Miyake N, Tsurusaki Y, Fukai R, Kushima I, Okamoto N, Ohashi K, et al. Molecular Diagnosis Of 405 Individuals With Autism Spectrum Disorder. Eur J Hum Genet. 2024;32:1551–8.

    Article  CAS  PubMed  Google Scholar 

  27. Bruno LP, Doddato G, Valentino F, Baldassarri M, Tita R, Fallerini C, et al. New Candidates for Autism/Intellectual Disability Identified by Whole-Exome Sequencing. Int J Mol Sci. 2021;22:13439.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  28. Du X, Gao X, Liu X, Shen L, Wang K, Fan Y, et al. Genetic Diagnostic Evaluation of Trio-Based Whole Exome Sequencing Among Children With Diagnosed or Suspected Autism Spectrum Disorder. Front Genet. 2018;9:594.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  29. Leppa VM, Kravitz SN, Martin CL, Andrieux J, Le Caignec C, Martin-Coignard D, et al. Rare Inherited and De Novo CNVs Reveal Complex Contributions to ASD Risk in Multiplex Families. Am J Hum Genet. 2016;99:540–54.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  30. Satterstrom FK, Kosmicki JA, Wang J, Breen MS, De Rubeis S, An JY, et al. Large-Scale Exome Sequencing Study Implicates Both Developmental and Functional Changes in the Neurobiology of Autism. Cell. 2020;180:568–584.e23.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  31. Cirnigliaro M, Chang TS, Arteaga SA, Pérez-Cano L, Ruzzo EK, Gordon A, et al. The Contributions Of Rare Inherited And Polygenic Risk To ASD In Multiplex Families. Proc Natl Acad Sci USA. 2023;120:e2215632120.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  32. Fan H, Lu J, Guo Y, Li D, Zhang ZM, Tsai YH, et al. BAHCC1 Binds H3k27me3 Via A Conserved Bah Module To Mediate Gene Silencing And Oncogenesis. Nat Genet. 2020;52:1384–96.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  33. Hezroni H, Ben-Tov Perry R, Gil N, Degani N, Ulitsky I. Regulation of Neuronal Commitment In Mouse Embryonic Stem Cells By The Reno1/Bahcc1 Locus. EMBO Rep. 2020;21:e51264.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  34. De Rubeis S, He X, Goldberg AP, Poultney CS, Samocha K, Cicek AE, et al. Synaptic, Transcriptional And Chromatin Genes Disrupted In Autism. Nature. 2014;515:209–15.

    Article  PubMed  PubMed Central  Google Scholar 

  35. Helsmoortel C, Vulto-van Silfhout AT, Coe BP, Vandeweyer G, Rooms L, van den Ende J, et al. SWI/SNF-Related Autism Syndrome Caused By De Novo Mutations In ADNP. Nat Genet. 2014;46:380–4.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  36. Garrido-Torres N, Marqués Rodríguez R, Alemany-Navarro M, Sánchez-García J, García-Cerro S, Ayuso MI, et al. Exploring Genetic Testing Requests, Genetic Alterations And Clinical Associations In A Cohort Of Children With Autism Spectrum Disorder. Eur Child Adolesc Psychiatry. 2024;33:3829–40.

    Article  PubMed  PubMed Central  Google Scholar 

  37. Amiet C, Couchon E, Carr K, Carayol J, Cohen D. Are There Cultural Differences In Parental Interest In Early Diagnosis And Genetic Risk Assessment For Autism Spectrum Disorder? Front Pediatr. 2014;2:32.

    Article  PubMed  PubMed Central  Google Scholar 

  38. Wang L, Wang B, Wu C, Wang J, Sun M. Autism Spectrum Disorder: Neurodevelopmental Risk Factors, Biological Mechanism, and Precision Therapy. Int J Mol Sci. 2023;24:1819.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  39. Clark MM, Stark Z, Farnaes L, Tan TY, White SM, Dimmock D, et al. Meta-Analysis of The Diagnostic And Clinical Utility Of Genome And Exome Sequencing And Chromosomal Microarray In Children With Suspected Genetic Diseases. NPJ Genom Med. 2018;3:16.

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgements

We would like to thank Ms. Niharika Jadeja and Ms. Tasneem Shaikh for their technical support in drafting the manuscript. The study was supported by an academic grant from MedGenome Labs, Bangalore.

Author information

Authors and Affiliations

Authors

Contributions

Shruti Bajaj: conceptualization, methodology, data analysis, data curation, clinical collaborator, drafting and critical review of the manuscript; Shreya Gandhi: data collection and analysis, drafting the manuscript; Thenral S. Geetha and Malini Venkata: conceptualization, methodology, data analysis, data curation, drafting and critical review of the manuscript; Anita Chitre: conceptualization, data curation, neuropsychological analysis of the participants, critical review of the manuscript; Nazema Sagi: project conceptualization, data curation, neuropsychological analysis of the participants, critical review of the manuscript; Nisha Agrawal: project conceptualization, data curation, neuropsychological analysis of the participants, critical review of the manuscript; Suhani Shah: data collection and analysis, drafting the manuscript; Ruta Deo: data collection and analysis, critical review of the manuscript; Sudharshana Pai, Kripa Saira Jacob, Sakthivel Murugan, Ramesh Menon, Ravi Gupta, Jeevana Praharsha Athota, Nagaraja M. Phani, Akshi Bassi, Sandeep Charugulla: data analysis, data curation, critical review of the manuscript; Vishakha Mali: data analysis, data curation, drafting the manuscript; Koyeli Sengupta, Puja Mehta, Vrajesh Udani, Pradnya Gadgil: clinical collaborator, data curation, critical review of the manuscript; Ramprasad Vedam: conceptualization, methodology, data analysis and curation, critical review of the manuscript; Anaita Udwadia Hegde: conceptualization, methodology, clinical collaborator, data analysis, drafting and critical review of the manuscript. All authors have contributed significantly to the preparation of this manuscript, have reviewed its contents, and have approved the final version for submission.

Corresponding authors

Correspondence to Shruti Bajaj or Anaita Udwadia Hegde.

Ethics declarations

Competing interests

The authors declare no competing interests.

Ethical approval

The authors confirm that the ethical policies of the journal, as noted on the journal’s author guidelines page, have been adhered to. The study was approved by an ethics committee, study number: R-202112.

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary information

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Bajaj, S., Gandhi, S., Geetha, T.S. et al. Prospective study to analyze the yield and clinical impact of trio exome sequencing in 137 Indian children with autism spectrum disorder. J Hum Genet 70, 611–624 (2025). https://doi.org/10.1038/s10038-025-01368-4

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Version of record:

  • Issue date:

  • DOI: https://doi.org/10.1038/s10038-025-01368-4

Search

Quick links